Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1955 1
1958 1
1964 1
1966 1
1972 1
1995 1
1997 1
1998 2
1999 2
2010 2
2011 1
2013 1
2016 1
2017 1
2019 2
2020 2
2021 1
2022 2
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

23 results

Results by year

Filters applied: . Clear all
Page 1
Vedolizumab as induction and maintenance therapy for Crohn's disease.
Sandborn WJ, Feagan BG, Rutgeerts P, Hanauer S, Colombel JF, Sands BE, Lukas M, Fedorak RN, Lee S, Bressler B, Fox I, Rosario M, Sankoh S, Xu J, Stephens K, Milch C, Parikh A; GEMINI 2 Study Group. Sandborn WJ, et al. N Engl J Med. 2013 Aug 22;369(8):711-21. doi: 10.1056/NEJMoa1215739. N Engl J Med. 2013. PMID: 23964933 Free article. Clinical Trial.
SPI-Hub™: a gateway to scholarly publishing information.
Koonce TY, Blasingame MN, Zhao J, Williams AM, Su J, DesAutels SJ, Giuse DA, Clark JD, Fox ZE, Giuse NB. Koonce TY, et al. Among authors: desautels sj. J Med Libr Assoc. 2020 Apr;108(2):286-294. doi: 10.5195/jmla.2020.815. Epub 2020 Apr 1. J Med Libr Assoc. 2020. PMID: 32256240 Free PMC article.
Using SPI-Hub™ to Promote the Key Role of Prepublishing in Healthcare.
Koonce TY, Blasingame MN, Williams AM, Zhao J, Su J, Epelbaum MI, Clark JD, Naylor HM, Kusnoor SV, DesAutels SJ, Giuse NB. Koonce TY, et al. Among authors: desautels sj. Stud Health Technol Inform. 2022 Jun 6;290:981-982. doi: 10.3233/SHTI220228. Stud Health Technol Inform. 2022. PMID: 35673166
Increased response and remission rates in short-duration Crohn's disease with subcutaneous certolizumab pegol: an analysis of PRECiSE 2 randomized maintenance trial data.
Schreiber S, Colombel JF, Bloomfield R, Nikolaus S, Schölmerich J, Panés J, Sandborn WJ; PRECiSE 2 Study Investigators. Schreiber S, et al. Am J Gastroenterol. 2010 Jul;105(7):1574-82. doi: 10.1038/ajg.2010.78. Epub 2010 Mar 16. Am J Gastroenterol. 2010. PMID: 20234346 Clinical Trial.
23 results